Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/148047
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Giménez, Neus |
dc.contributor.author | Martínez-Trillos, Alejandra |
dc.contributor.author | Montraveta, Arnau |
dc.contributor.author | Lopez Guerra, Mónica |
dc.contributor.author | Rosich, Laia |
dc.contributor.author | Nadeu, Ferran |
dc.contributor.author | Valero, Juan G. |
dc.contributor.author | Aymerich Gregorio, Marta |
dc.contributor.author | Magnano, Laura |
dc.contributor.author | Rozman, María |
dc.contributor.author | Matutes, Estella |
dc.contributor.author | Delgado, Julio |
dc.contributor.author | Baumann, Tycho |
dc.contributor.author | Gine, Eva |
dc.contributor.author | González, Marcos |
dc.contributor.author | Alcoceba, Miguel |
dc.contributor.author | Terol, M.José |
dc.contributor.author | Navarro, Blanca |
dc.contributor.author | Colado, Enrique |
dc.contributor.author | Payer, Angel R. |
dc.contributor.author | Puente, Xose S. |
dc.contributor.author | López Otín, Carlos |
dc.contributor.author | López-Guillermo, Armando |
dc.contributor.author | Campo Güerri, Elias |
dc.contributor.author | Colomer Pujol, Dolors |
dc.contributor.author | Villamor i Casas, Neus |
dc.date | 2020-01-16T15:18:40Z |
dc.date | 2020-01-16T15:18:40Z |
dc.date | 2019-03 |
dc.date | 2020-01-16T15:18:40Z |
dc.identifier.citation | 0390-6078 |
dc.identifier.citation | 682538 |
dc.identifier.citation | 3998691 |
dc.identifier.uri | http://hdl.handle.net/2445/148047 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Ferrata Storti Foundation |
dc.relation | Reproducció del document publicat a: https://doi.org/10.3324/haematol.2018.196931 |
dc.relation | Haematologica, 2019, vol. 104, num. 3, p. 576-586 |
dc.relation | https://doi.org/10.3324/haematol.2018.196931 |
dc.rights | (c) Ferrata Storti Foundation, 2018 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Leucèmia limfocítica crònica |
dc.subject | Mutació (Biologia) |
dc.subject | Chronic lymphocytic leukemia |
dc.subject | Mutation (Biology) |
dc.title | Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |